Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
5
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
US Stock MarketDetailed Quotes
Nkarta (NKTX)
- 2.510
- -0.260-9.39%
Close Jun 5 16:00 ET
- 2.480
- -0.030-1.20%
Post 19:10 ET
179.58MMarket Cap-1.86P/E (TTM)
2.770High2.490Low564.05KVolume2.760Open2.770Prev Close1.45MTurnover0.93%Turnover RatioLossP/E (Static)71.55MShares3.65052wk High0.63P/B151.73MFloat Cap1.63052wk Low--Dividend TTM60.45MShs Float79.160Historical High--Div Yield TTM10.11%Range %1.280Historical Low2.568Avg Price1Lot Size
Nkarta (NKTX) News
Evercore Initiates Nkarta(NKTX.US) With Buy Rating, Announces Target Price $9
Nkarta (NKTX) Gets a Buy From Stifel Nicolaus
Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX), PROCEPT BioRobotics (PRCT) and Lineage Therap (LCTX)
Needham Reiterates Buy on Nkarta, Maintains $11 Price Target
Nkarta Buy Rating Reaffirmed as NKX019 Autoimmune Trials Advance; $16 Price Target Maintained
Nkarta GAAP EPS of -$0.37 In-line
Nkarta Q1 EPS $(0.37), Inline
Nkarta | 10-Q: Quarterly report
Nkarta: Cash Balance of $266.7 M, Including Cash, Cash Equivalents and Investments, Expected to Fund Ops Into 2029 >NKTX
Nkarta | 8-K: Nkarta Reports First Quarter 2026 Financial Results and Corporate Highlights
Press Release: Nkarta Reports First Quarter 2026 Financial Results and Corporate Highlights
Express News | Nkarta Q1 Net Income USD -27.832 Million
Nkarta 1Q Loss $27.8M >NKTX
Nkarta Reports First Quarter 2026 Financial Results and Corporate Highlights
Nkarta Shares Are Trading Higher After the Company Announced an Agreement With the FDA on Protocols for Its Ntrust-1 and Ntrust-2 Clinical Trials.
Stifel Maintains Nkarta(NKTX.US) With Buy Rating, Maintains Target Price $11
Analysts Are Bullish on These Healthcare Stocks: Nkarta (NKTX), Harrow Health (HROW)
Needham Maintains Nkarta(NKTX.US) With Buy Rating, Maintains Target Price $11
Analysts' Opinions Are Mixed on These Healthcare Stocks: Biogen (BIIB) and Nkarta (NKTX)
H.C. Wainwright Maintains Nkarta(NKTX.US) With Buy Rating, Maintains Target Price $16
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On June 3, Eastern Time, the U.S. House of Representatives passed a resolution limiting Trump's authority to use military force against Iran
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm